ABT
Company research profile within the AtechFuture CORE30 universe.
Capital efficiency, operating profitability and free cash flow.
Revenue, EBITDA and free cash flow growth.
Network, customer lock-in and structural advantages.
Financial Fundamentals
ROIC
7.5%Operating Margin
17.1%FCF Margin
16.3%Growth Performance
Revenue CAGR 3Y
5.0%EBITDA CAGR 3Y
7.8%FCF CAGR 3Y
12.5%Competitive Advantages
Abbott has built a diversified healthcare moat through clinical evidence, product reliability, and medical distribution channels across medical devices, diagnostics, and nutrition products. Key factors to watch include Libre growth, medical device innovation, recovery in diagnostics, and profitability across its business segments.
Network & Ecosystem
88.0 / 100Customer & Technology Lock-in
91.0 / 100Structural Advantage
91.0 / 100Research Timeline
Material Business Events
No material business events recorded.
Research Conclusion Changes
No material research conclusion changes recorded.